(AXON) Axon Enterprise - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NASDAQ (USA) | Market Cap: 31.161m USD | Total Return: -47.2% in 12m
Stun Guns, Body Cameras, Evidence Software, Drones
Total Rating 40
Safety 80
Buy Signal -0.13
Aerospace & Defense
Industry Rotation: +0.2
Industry Rotation: +0.2
Market Cap:
31.2B
Avg Turnover: 412M
Avg Turnover: 412M
Risk 3d forecast
Volatility60.1%
VaR 5th Pctl8.57%
VaR vs Median-19.3%
Reward TTM
Sharpe Ratio-1.02
Rel. Str. IBD5.3
Rel. Str. Peer Group8.5
Character TTM
Beta0.764
Beta Downside0.209
Hurst Exponent0.666
Drawdowns 3y
Max DD60.28%
CAGR/Max DD0.44
CAGR/Mean DD1.95
EPS (Earnings per Share)
EPS CAGR: 41.33%
EPS Trend: 87.0%
EPS Trend: 87.0%
Last SUE: 0.03
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 31.93%
Rev. Trend: 99.9%
Rev. Trend: 99.9%
Last SUE: 2.40
Qual. Beats: 2
Qual. Beats: 2
Warnings
P/E ratio 155.9
High Debt/EBITDA (7.1) with thin interest coverage (0.9)
Interest Coverage Ratio 0.9 is critical
Tailwinds
No distinct edge detected
Description: AXON Axon Enterprise
Axon Enterprise, Inc. specializes in public safety technologies, operating through its Software and Services and Connected Devices segments. The company develops and manufactures hardware including TASER conducted energy devices, body-worn cameras, and fleet imaging systems. Its software ecosystem, led by Axon Evidence, provides a cloud-based platform for digital evidence management, data analysis, and reporting for law enforcement and government agencies.
The business model relies on a razor-and-blade strategy, where hardware sales often secure long-term, high-margin Software-as-a-Service (SaaS) contracts. This integration creates high switching costs for municipal clients, a common characteristic in the defense and public safety sector where interoperability between hardware and data storage is critical for legal compliance.
Investors should review the detailed fundamental analysis on ValueRay to better understand the companys valuation metrics.
Headquartered in Scottsdale, Arizona, Axon has expanded its product suite to include drone technologies and virtual reality training. Formerly known as TASER International, the firm rebranded in 2017 to reflect its shift toward a comprehensive digital safety infrastructure serving federal, state, and commercial markets.
- High-margin software subscription growth accelerates annual recurring revenue and operating leverage
- Expansion of AI-powered transcription and reporting tools drives digital evidence management demand
- Increased global police department adoption of TASER 10 hardware secures long-term contracts
- Federal government and international market penetration reduces reliance on domestic municipal budgets
- Rising cloud storage costs and hardware supply chain disruptions impact gross margins
Piotroski VR‑10 (Strict)
3.5
| Net Income: 206.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -5.68 > 1.0 |
| NWC/Revenue: 51.48% < 20% (prev 109.6%; Δ -58.12% < -1%) |
| CFO/TA 0.02 > 3% & CFO 154.0m > Net Income 206.2m |
| Net Debt (1.37b) to EBITDA (192.6m): 7.11 < 3 |
| Current Ratio: 2.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (82.5m) vs 12m ago 1.22% < -2% |
| Gross Margin: 59.32% > 18% (prev 0.61%; Δ 5.87k% > 0.5%) |
| Asset Turnover: 45.37% > 50% (prev 36.60%; Δ 8.78% > 0%) |
| Interest Coverage Ratio: 0.90 > 6 (EBITDA TTM 192.6m / Interest Expense TTM 115.1m) |
Altman Z''
2.37
| A: 0.22 (Total Current Assets 2.74b - Total Current Liabilities 1.21b) / Total Assets 7.07b |
| B: 0.16 (Retained Earnings 1.11b / Total Assets 7.07b) |
| C: 0.02 (EBIT TTM 103.5m / Avg Total Assets 6.58b) |
| D: 0.31 (Book Value of Equity 1.09b / Total Liabilities 3.53b) |
| Altman-Z'' Score: 2.37 = BBB |
Beneish M
-2.63
| DSRI: 0.67 (Receivables 870.3m/974.1m, Revenue 2.98b/2.23b) |
| GMI: 1.02 (GM 59.32% / 60.57%) |
| AQI: 1.68 (AQ_t 0.56 / AQ_t-1 0.34) |
| SGI: 1.34 (Revenue 2.98b / 2.23b) |
| TATA: 0.01 (NI 206.2m - CFO 154.0m) / TA 7.07b) |
| Beneish M-Score: -2.63 (Cap -4..+1) = A |
What is the price of AXON shares?
As of May 20, 2026, the stock is trading at USD 392.34 with a total of 747,635 shares traded.
Over the past week, the price has changed by -0.34%, over one month by -2.83%, over three months by -11.06% and over the past year by -47.15%.
Over the past week, the price has changed by -0.34%, over one month by -2.83%, over three months by -11.06% and over the past year by -47.15%.
Is AXON a buy, sell or hold?
Axon Enterprise has received a consensus analysts rating of 4.24.
Therefore, it is recommended to buy AXON.
- StrongBuy: 7
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AXON price?
| Analysts Target Price | 662 | 68.7% |
Axon Enterprise (AXON) - Fundamental Data Overview
as of 20 May 2026
P/E Trailing = 155.8871 P/E Forward = 48.5437
P/S = 10.4452
P/B = 8.9376
P/EG = 1.6448
Revenue TTM = 2.98b USD
EBIT TTM = 103.5m USD
EBITDA TTM = 192.6m USD
Long Term Debt = 1.73b USD (from longTermDebt, last quarter)
Short Term Debt = 80.6m USD (from shortTermDebt, last fiscal year)
Debt = 1.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.37b USD (from netDebt column, last quarter)
Enterprise Value = 32.27b USD (31.16b + Debt 1.83b - CCE 718.9m)
Interest Coverage Ratio = 0.90 (Ebit TTM 103.5m / Interest Expense TTM 115.1m)
EV/FCF = 1000.0x (Enterprise Value 32.27b / FCF TTM 19.5m)
FCF Yield = 0.06% (FCF TTM 19.5m / Enterprise Value 32.27b)
FCF Margin = 0.65% (FCF TTM 19.5m / Revenue TTM 2.98b)
Net Margin = 6.91% (Net Income TTM 206.2m / Revenue TTM 2.98b)
Gross Margin = 59.32% ((Revenue TTM 2.98b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 59.12% (prev 57.90%)
Tobins Q-Ratio = 4.57 (Enterprise Value 32.27b / Total Assets 7.07b)
Interest Expense / Debt = 1.57% (Interest Expense 28.6m / Debt 1.83b)
Taxrate = 15.44% (30.9m / 200.2m)
NOPAT = 87.5m (EBIT 103.5m * (1 - 15.44%))
Current Ratio = 2.27 (Total Current Assets 2.74b / Total Current Liabilities 1.21b)
Debt / Equity = 0.52 (Debt 1.83b / totalStockholderEquity, last quarter 3.53b)
Debt / EBITDA = 7.11 (Net Debt 1.37b / EBITDA 192.6m)
Debt / FCF = 70.19 (Net Debt 1.37b / FCF TTM 19.5m)
Total Stockholder Equity = 3.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.14% (Net Income 206.2m / Total Assets 7.07b)
RoE = 6.58% (Net Income TTM 206.2m / Total Stockholder Equity 3.13b)
RoCE = 2.13% (EBIT 103.5m / Capital Employed (Equity 3.13b + L.T.Debt 1.73b))
RoIC = 1.74% (NOPAT 87.5m / Invested Capital 5.02b)
WACC = 8.26% (E(31.16b)/V(32.99b) * Re(8.67%) + D(1.83b)/V(32.99b) * Rd(1.57%) * (1-Tc(0.15)))
Discount Rate = 8.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 82.22 | Cagr: 3.59%
[DCF] Terminal Value 80.73% ; FCFF base≈156.7m ; Y1≈193.4m ; Y5≈329.9m
[DCF] Fair Price = 49.72 (EV 5.38b - Net Debt 1.37b = Equity 4.01b / Shares 80.6m; r=8.26% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 87.04 | EPS CAGR: 41.33% | SUE: 0.03 | # QB: 0
Revenue Correlation: 99.85 | Revenue CAGR: 31.93% | SUE: 2.40 | # QB: 2
EPS current Quarter (2026-06-30): EPS=1.83 | Chg30d=+0.68% | Revisions=+9% | Analysts=18
EPS next Quarter (2026-09-30): EPS=2.02 | Chg30d=-0.77% | Revisions=-5% | Analysts=18
EPS current Year (2026-12-31): EPS=7.69 | Chg30d=-1.24% | Revisions=+4% | GrowthEPS=+12.2% | GrowthRev=+31.5%
EPS next Year (2027-12-31): EPS=10.57 | Chg30d=+0.04% | Revisions=+27% | GrowthEPS=+37.5% | GrowthRev=+29.3%
[Analyst] Revisions Ratio: +27%